Home > About us

Nova Test

What is a Nova Test kit and how does it work?

The worldwide economies are now facing a great setback, owing to the eruption of the COVID-19. This pandemic is considered a really threatening disease because it affects all categories of people all over the world. That's the reason of why being a member of the big family of viruses, coronavirus spread by COVID-19 causes different illnesses, ranging from the common cold to harsher syndromes, such as MERS-CoV or Middle East Respiratory Syndrome and SARS-CoV or Severe Acute Respiratory Syndrome.

NOVA test is a trademark of medical precision diagnosis in IVD under Atlas-Link. The trademark was registered in 2009. At present, there are more than 40 products sold with this trademark, which have been sold in 90 countries in more than 10 years. Among them, the NOVA test brand has a high market share in many countries in South America and the Middle East. NOVA test series products have the characteristics of high product performance, strong specificity, short detection time, high sensitivity, etc. They are widely praised in the customer base! Among them, HCG, LH, FOB, cardiac troponin and other products are the main products of the brand. In the past two years, NOVA test has begun to transform to the rapid diagnosis of infectious diseases. Especially in the COVID-19 in 2020,NOVA test had launched a new series of new coronavirus detection products (IgM/IgG antibody rapid test, IgM-IgG total antibody rapid test), and quickly obtained a large number of orders with its good quality and occupied the market in many countries. At the same time, NOVA test also launched a series of rapid diagnostic kits for HIV, HCV, syphilis, Zika virus and other infectious diseases.

The Nova Test Kits are capable of detecting all types of new strains, which have not been previously recognized in humans. They are not only quite helpful in detecting a variety of mild symptoms of the COVID-19 disease, such as respiratory symptoms, cough, fever, shortness of breath, as well as breathing troubles. They are also extremely handy in diagnosing severe cases, the disease that causes pneumonia, harsh acute respiratory disease, kidney failure, and even death.

The Nova Test Covid-19 IgM/IgG Antibody Test bases on the immunochromatography platform.The recombinant COVID-19 antigen and mouse IgG antibodies are tagged with colloidal gold as a tracer. After adding the samples, if IgM antibodies of 2019-nCoV are present , the antibodies will connect to colloidal gold-layered 2019nCoV antigens to structure compounds, which are captured further by the mouse-anti human IgM antibodies to shape new compounds and create the purple line. The binding of these antibodies with the antibodies of goat-anti -mouse IgG will present the purple line, which is employed as the control line.

The Nova Test Kits of Atlas-Link can be effectively used to detect the coronavirus from a variety of samples, including plasma, serum and whole blood. These kits are exclusively designed for the qualitative detection of IgG and IgM antibodies against the new coronavirus in human plasma, serum, and whole blood samples. They are also used as an additional detection pointer for new supposed cases for detecting the negative coronavirus nucleic acid or in combination with nucleic acid discovery in the diagnosis of doubtful cases.

 The intended use of Nova Test kits of Atlas-Link is to balance the nucleic acid test and other medical analytic tools for COVID-19. They can be used to detect the virus spread by the new COVID-19 as well as other types of viruses and bacteria confidently. This is the reason for why these kits are perfectly designed to offer reliable and accurate results.

The Nova Test kits can also be used as a non-diagnostic reference to make sure whether the antibody IgG or IgM is generated in the blood of an individual against the COVID-19 virus after 5 to 15 days infection. For this antibody verification purpose, the blood sample of a person needs to be obtained two to three times with three to five days interval to observe positive results based on the nature of the immune response as well as the antibody generation timeline of the individual.